Trupanion (NASDAQ:TRUP – Get Free Report) issued its quarterly earnings results on Wednesday. The financial services provider reported $0.04 EPS for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02), Zacks reports. Trupanion had a negative net margin of 1.08% and a negative return on equity of 4.36%.
Trupanion Stock Down 2.4 %
Shares of TRUP traded down $1.18 during trading hours on Wednesday, reaching $47.51. The stock had a trading volume of 668,659 shares, compared to its average volume of 508,901. The firm has a 50-day simple moving average of $48.54 and a 200 day simple moving average of $47.98. Trupanion has a 12 month low of $19.69 and a 12 month high of $57.90. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.40. The company has a market capitalization of $2.01 billion, a price-to-earnings ratio of -148.47, a P/E/G ratio of 8.66 and a beta of 1.60.
Analyst Ratings Changes
TRUP has been the topic of a number of recent analyst reports. Piper Sandler raised Trupanion from a “neutral” rating to an “overweight” rating and set a $57.00 price objective on the stock in a research note on Thursday, January 23rd. Stifel Nicolaus boosted their price target on Trupanion from $42.00 to $44.00 and gave the company a “hold” rating in a research note on Monday, January 6th. Finally, Northland Securities raised their price objective on shares of Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a research report on Thursday, October 31st. Two analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $45.33.
Insider Buying and Selling at Trupanion
In related news, SVP Emily Dreyer sold 3,100 shares of Trupanion stock in a transaction that occurred on Friday, November 22nd. The stock was sold at an average price of $54.85, for a total transaction of $170,035.00. Following the transaction, the senior vice president now owns 24,708 shares of the company’s stock, valued at $1,355,233.80. The trade was a 11.15 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Fawwad Qureshi sold 9,867 shares of the stock in a transaction on Friday, November 29th. The shares were sold at an average price of $53.08, for a total value of $523,740.36. The disclosure for this sale can be found here. In the last 90 days, insiders sold 26,597 shares of company stock worth $1,416,742. 5.50% of the stock is owned by corporate insiders.
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Stories
- Five stocks we like better than Trupanion
- Pros And Cons Of Monthly Dividend Stocks
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- Bank Stocks – Best Bank Stocks to Invest In
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- What is the NASDAQ Stock Exchange?
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.